Fly News Breaks for February 13, 2020
Feb 13, 2020 | 07:29 EDT
Raymond James analyst John Hsu raised his price target for Quidel to $92 from $70 and maintained a Strong Buy rating following a "solid" Q4 print driven by a strong flu performance, the highest Q4 since the 2009 flu pandemic. In a research note to investors, Hsu says he sees room for upside to the company's guidance of at least $50M in Q1 flu revenue, and thinks Q1 flu revenue could track north of $55M if the seasonal strength continues.
News For QDEL From the Last 2 Days